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Acid extracts of rat anterior pituitary cells and cell-derived culture media were shown to contain three forms 
of fl-endorphin immunoreactive peptides, corresponding in molecular size to the prohormone pro-opiomela- 
nocortin (POMC), j?-lipotropin and 3.5 kDa /I-endorphin, and essentially two forms of adrenocorticotropin 
(ACTH) immunoreactivity, representing a 20 kDa intermediate fragment and 4.5 kDa ACTH. Under basal 
conditions the intracellular peptides contained a high proportion of the bioactive forms of B-endorphin and 
ACTH whereas the extracellular peptides contained a higher proportion of the inactive precursors. When 
the cells were incubated for 3 h in the presence of 10m8 M CRF, the levels of intracellular /Lendorphin and 
ACTH immunoreactivity were reduced by 15-30% and there was a 4-5-fold increase in the level of the 
secreted peptides; furthermore, unlike the peptides released under basal conditions, the peptides secreted 
under the influence of CRF contained much higher proportions of 4.5 kDa ACTH and 3.5 kDa /3-endor- 
phin, reflecting the intracellular patterns of these peptides. Similar results were obtained when secretion was 
stimulated by lo-’ M epinephrine, which produced a 2-fold increase in peptide release. In the presence of
10e6 M dexamethasone th basal secretion of ACTH and /?-endorphin related peptides, and the intracellular 
levels of these peptides, remained unaltered. The results point to the existence ofdifferent intracellular com- 
partments from which peptides at different states of maturation can be released selectively. 
j?-Endorphin ACTH Pituitary cell culture Processing CRF Epirzephrine 
1. INTRODUCTION 
Pro-opiomelanocortin (POMC), the precursor 
of the bioactive peptides adrenocorticotropin 
(ACTH), &endorphin and ry-melanocyte- 
stimulating hormone ((Y-MSH), is synthesised in 
the brain where the end products appear to serve as 
neurotransmitters [l-3] and in the pituitary where 
the peptides are stored preparatory to release as 
hormones [4,5]. The extent of conversion of 
POMC to its bioactive fragments, however, varies 
from tissue to tissue. In rat pars intermedia, for ex- 
ample, processing of the prohormone proceeds 
nearly to completion, generating the acetylated 
forms of wMSH and the shortened forms of ,8- 
endorphin as the major peptides [6-91; in contrast, 
proteolysis of POMC in the pars distalis is less 
complete, yielding predominantly ACTH and ,8- 
lipotropin [5,8,10]. This ‘tissue specific’ processing 
of POMC is also evident in regions of brain; 
desacetyl cu-MSH and fi-endorphin are the main 
products in rat hypothalamus [7,1 l] whereas 
acetylated and truncated forms of these peptides 
are present in regions distal from the 
hypothalamus [7,11,12]. Thus, variations in the 
processing of the POMC prohormone serve to 
generate different bioactivities in different tissues. 
An interesting aspect of POMC processing is 
that the processing reactions can generate prohor- 
mone fragments that are highly active together 
with related peptides that are virtually inactive. In 
the pars intermedia, for example, ,B-endorphin 
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which is a potent analgesic agent [13] can be pro- 
cessed to generate acetylated derivatives which are 
essentially devoid of analgesic activity [ 14,151; and 
these inactivated peptides occur in company with 
acetylated forms of m-MSH which are highly po- 
tent [ 161. In this way a complementary relationship 
may exist between different biological activities 
generated from a common prohormone through 
the potentiation of one activity and attenuation of 
another. 
Recently we reported that the processing of 
POMC in rat pars intermedia is sensitive to the 
presence of dopaminergic agonists which not only 
inhibit the rate of secretion but also alter the pat- 
tern of peptides secreted [17]. It appears that the 
processing of POMC in the pars intermedia is 
linked to secretion: in particular when the cells are 
in a dynamic state of secretion, processing of the 
POMC prohormone is directed towards the forma- 
tion of bioactive products whereas under condi- 
tions of basal secretion it is principally the inactive 
forms that are released. Here we report that under 
conditions of stimulated secretion the principal 
forms of ACTH and ,8-endorphin released from 
the pars distalis of the pituitary are the bioactive 
peptides, 3.5 kDa ,&endorphin and 4.5 kDa 
ACTH. 
2. MATERIALS AND METHODS 
2.1. Preparation of primary cultures of rat 
anterior pituitary cells 
Monolayers of rat anterior pituitary cells were 
prepared by the method of Kirkland and Ellison 
[ 181. For experimental treatments the cells were in- 
cubated for 3 or 6 h in the presence and absence of 
10e8 M ovine corticotrophin-releasing factor (RIA 
UK Ltd), lo-’ M epinephrine bitartrate (Sigma) 
and 10e6 M dexamethasone sodium phosphate 
(kindly donated by Merck, Sharp and Dohme); the 
anti-oxidant ascorbic acid (final concentration 
100 pg/ml) was included. 
2.2. Extraction of ,8-endorphin and AkTH related 
peptides 
Cell monolayers were harvested by scraping the 
cells into ice-cold acetic acid (20%, v/v) with the 
aid of a silicon rubber policeman. The cell extracts 
were rapidly homogenised at 4”C, centrifuged for 
20 mitt, 40000 x g at 4°C and the supernatants ap- 
254 
plied directly to gel exclusion chromatography or 
lyophilised for storage. Cell-exposed culture 
medium was acidified with hydrochloric acid 
(0.1 ml of 1 M HCl: 5 ml culture medium), 
lyophilized and reconstituted in 20% acetic acid 
prior to chromatography. 
2.3. Chromatography and radioimmunoassay 
,fJ-Endorphin and ACTH related peptides were 
resolved by gel exclusion and ion-exchange 
chromatography using respectively Sephadex G-75 
and SP-Sephadex C-25 (pyridinium form) as in 
[ 191. ACTH measurements were made by radioim- 
munoassay using an antiserum raised against por- 
cine ACTH coupled to thyroglobulin; its specifici- 
ty was directed against the mid-region of ACTH. 
The procedure employed was similar to that used 
for the P-endorphin assay [ll]. The specificity of 
the P-endorphin antiserum was directed towards 
the carboxyl terminus. Both antisera were used at 
a final dilution of 1: 16000. 
3. RESULTS 
In 2 cultures of anterior pituitary cells which 
were incubated with 10e8 M CRF for 3 or 6 h, 
there was a substantial increase in the level of 
secreted P-endorphin and ACTH related peptides 
(fig. l), concomitant with a fall in the intracellular 
levels. In addition the level of the total im- 
munoreactive peptides (intracellular and ex- 
tracellular) related to ,&endorphin and ACTH was 
higher (30% above control) for the CRF-treated 
cultures than for the untreated cells. Similar 
findings were observed with lo-’ M epinephrine as 
secretagogue when a 2-fold increase in secretion 
occurred; this stimulated secretion was again ac- 
companied by a decrease in the level of the in- 
tracellular peptides. When the cultures were in- 
cubated in the presence of lop6 M dexamethasone, 
the basal secretion of ACTH and P-endorphin 
related peptides and the intracellular levels of these 
peptides were essentially unaltered. 
Acid extracts of cells and cell-derived culture 
media were subjected to gel-exclusion chro- 
matography, showing different patterns of both /3- 
endorphin and ACTH immunoreactivity. The in- 
tracellular and extracellular extracts contained 3 
forms of ,&endorphin immunoreactivity, cor- 
responding to POMC prohormone, ,8-lipotropin 
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Fig. 1. The effects of corticotrophin-releasing factor, adrenalin (epinephrine) and dexamethasone on intracellular and 
extracellular immunoreactive fl-endorphin and ACTH in rat primary anterior pituitary cultures. 
and 3.5 kDa ,&endorphin, and 2 peaks of ACTH 
immunoreactivity, one eluting in the position of 
4.5 kDa ACTH and the other in a position cor- 
responding to an apparent molecular mass of 
20-25 kDa (figs 2-4). Further purification by ion- 
Fraction Number 
Fig.2. Gel-exclusion resolution of (a) &endorphin 
related peptides and (b) ACTH related peptides, in 
extracts of rat anterior pituitary cells. The arrow 
indicates the elution position of rZ51-@-endorphin l-3 1. 
exchange chromatography showed that the ,8- 
endorphin sized material resolved by gel exclusion 
consisted of a single chromatographic omponent 
which co-eluted with “‘I-porcine P-endorphin 
1-31; there was no evidence for the presence of a 
significant amount of the 26- and 27-residue forms 
of P-endorphin (fig.5). 
Examination of the gel exclusion profiles of ,9- 
endorphin and ACTH peptides in extracts of con- 
trol anterior pituitary cells (fig.2) showed that 
3.5 kDa ,&endorphin and 4.5 kDa ACTH 
represented approx. 50% of the total respective 
immunoactivities. In the culture medium the level 
of these peptides was considerably reduced (figs 3 
and 4); the predominant peptides secreted under 
basal conditions were the larger, precursor forms 
of ,f3-endorphin and ACTH. In contrast, in the 
presence of CRF the levels of 3.5 kDa ,&-endorphin 
and 4.5 kDa ACTH secreted into the culture 
medium were increased relative to the total p- 
endorphin or total ACTH immunoreactivity (figs 3 
and 4); the patterns of peptides secreted from these 
cells resembled the intracellular patterns 
characteristic of both the control cells and the 
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Fig.3. Gel-exclusion resolution of secreted fl-endorphin 
related peptides from control and CRF-treated rat 
anterior pituitary cells. The arrow indicates the elution 
position of ‘251-&endorphin l-3 1. 
CRF-treated cells. This enhancement of 3.5 kDa& 
endorphin and 4.5 kDa ACTH in the peptides 
secreted under the influence of CRF was also seen 
in the epinephrine-treated cultures, though the ef- 
fects were less marked. In the presence of 10m6 M 
dexamethasone the profiles of intracellular and ex- 
tracellular &endorphin and intracellular and ex- 
tracellular ACTH did not differ from the patterns 
exhibited by the control cells. 
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Fig.4. Gel exclusion resolution of secreted ACTH- 
related peptides from control and CRF-treated rat 
anterior pituitary cells. The arrow indicates the elution 
position of ‘251-,&endorphin l-3 1. 
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Fig.5. Ion-exchange chromatographic resolution of p- 
endorphin size peptides secreted from rat control 
anterior pituitary cells (showing that &endorphin l-3 1 
is the major peptide). The arrows from left to right 
indicate the elution positions of radio-labelled lz51- 
reference markers: a-N-acetyl ,&endorphin l-27, fl- 
endorphin l-27, cu-N-acetyl P-endorphin l-31 and fl- 
endorphin l-31. 
It should be noted that in these experiments 
complete resolution of 13 kDa ACTH (gly- 
cosylated ACTH) from 20 kDa ACTH was not 
achieved with the methods employed; however, the 
glycosylated peptide has been reported to be only 
a minor component of the total ACTH present in 
rat anterior pituitary [6]. 
4. DISCUSSION 
The finding that anterior pituitary cells under 
basal conditions secrete preferentially higher 
molecular mass peptides while the peptides 
secreted under stimulus are mainly the bioactive 
forms suggests that distinct pools of POMC 
related peptides may exist, one destined for secre- 
tion and another for storage. This is consistent 
with the data of Gumbiner and Kelly [20] who have 
proposed that 2 intracellular transport pathways 
are operative in the AtT-20 pituitary cell line. 
256 
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Another possibility which could account for the 
different intracellular and extracellular patterns is 
that the secreted peptides might originate from 
more than one cell type: under basal, non- 
stimulated conditions secretion would appear to 
take place from cells containing immature precur- 
sor peptides whereas under stimulated conditions 
of secretion cells containing principally the bioac- 
tive peptides could be called into the secretory 
pathway. In this context it should be noted that 
Deftos and Catherwood [21], using immunoperox- 
idase techniques, obtained evidence for the ex- 
istence of different populations of POMC- 
containing cells in the anterior pituitary, one type 
elaborating both ACTH-related and &endorphin 
related peptides and another only ACTH-related 
peptides; the different cell types, however, could 
also reflect various states of maturity of the cor- 
ticotrophs. Nevertheless, the existence of either 
different . cell types or different peptide pools 
would offer an explanation for the patterns of pep- 
tides secreted in the presence of the secretagogues, 
CRF and epinephrine. 
During CRF stimulated secretion the total 
ACTH and ,&endorphin related peptides (stored + 
released) exceeded the levels of these peptides in 
the control cells, suggesting that de novo synthesis 
of POMC was increased or that degradation of the 
biosynthetic products was inhibited. Increased syn- 
thesis is less likely since the cells were exposed to 
CRF for no more than 6 h. It has been shown 
previously that the intracellular levels of ACTH in 
vitro [22] and POMC mRNA in vivo [23] increase 
only after chronic stimulation with a secretagogue 
over a period of several days. The postulation of 
decreased rates of intracellular degradation is more 
attractive as it would tend to restore the bioactive 
peptides lost to the cell during secretion. In this 
context it has been demonstrated by pulse chase 
studies in AtT-20 cells that intracellular degrada- 
tion of fl-endorphin is strongly inhibited when the 
cells are exposed to CRF (S. Cockle, personal 
communication). 
It should be noted that the mode of action of 
CRF and epinephrine is not fully understood. 
Evidence has been obtained that CRF stimulated 
secretion is mediated via specific receptors and is 
CAMP dependent [24]; in contrast epinephrine ap- 
pears to act through a different pathway [25]. Fur- 
thermore the action of CRF can be potentiated by 
synergism with other hormones such as 
vasopressin, oxytocin and epinephrine [25,26]. 
Since the intracellular and extracellular peptide 
patterns are similar under conditions of dynamic 
secretion, it would appear that the processing reac- 
tions involved in the cleavage of POMC are not 
directly affected by the secretion stimulus. It might 
be anticipated that during rapid secretion the 
degree of processing would be reduced because of 
diminished exposure to the processing enzymes. 
On the contrary, the gel-exclusion profiles ob- 
tained in our experiments uggest hat during the 
secretory period the rate of processing is in fact in- 
creased, though the increased processing may be 
counterbalanced in part by a decrease related to 
augmented secretion. While further study will be 
necessary to clarify the specific actions of CRF and 
related secretagogues, the present results indicate 
that both inhibition of degradation and stimula- 
tion of processing take place during secretion. 
That &endorphin is co-released with ACTH 
from the anterior pituitary suggests that this opiate 
peptide may play a supportive role in modulating 
biological responses under stress, possibly by 
regulating the mobility of the gastrointestinal tract 
[27] or in the regulation of chromaffin cell activity 
[28]. In the present experiments the predominance 
of total ,&endorphin immunoreactivity over total 
ACTH immunoreactivity (molar ratio 4 : 1) during 
both basal and the early stages of stimulated secre- 
tion is surprising since ACTH and fl-endorphin 
related peptides are generated from a common 
prohormone and would be expected to occur in 
stoichiometric amounts. It is of interest that 
similar findings have been reported in a study of 
the stored and released peptides of AtT-20 cells 
[29]. It is, of course, possible that the precursor 
forms of ACTH are less reactive than 4.5 kDa 
ACTH in the ACTH radioimmunoassay whereas 
POMC, ,&lipotropin and&endorphin appear to be 
equally reactive in the fl-endorphin RIA. Alter- 
natively, the imbalance could be due to differential 
rates of degradation or selective secretion of the 
ACTH and fl-endorphin related peptides. 
The main finding of this study is that the pat- 
terns of peptides secreted from cultured anterior 
pituitary cells do not always correspond to the in- 
tracellular patterns. Thus the peptides secreted 
under basal conditions would appear to originate 
from different intracellular pools, or from dif- 
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ferent cell types, than the peptides that are secreted 
under the influence of secretagogues. Our findings 
are in agreement with the results of Allan et al. 
[30], using mouse anterior pituitary cells, and 
those of Mains and Eipper [31] employing AtT-20 
cells. Furthermore, the suggestion that the 
cleavage of POMC to lipotropin occurs earlier and 
in a different compartment from that where the 
cleavage of/?-lipotropin to&endorphin takes place 
[32] is compatible with the existence of different 
pools within a cell. The different pools may re- 
spond to different secretory signals. 
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